TribLIVE

| Business

 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Complexa raises $13M to fund trials of kidney disease drug

Email Newsletters

Click here to sign up for one of our email newsletters.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

Wednesday, June 4, 2014, 10:51 a.m.
 

Complexa Inc., a South Side-based drug development company, said it raised $13 million from investors that will fund clinical trials of a drug to treat kidney disease.

The funding round, Complexa's second, was led by Jafco Life Science Investment, an arm of Japanese private equity firm Jafco Co. Ltd.

The company previously raised more than $8 million from venture capital investors to license and develop molecules discovered and patented by professor Bruce Freeman and a team of researchers at the University of Pittsburgh.

There is “great interest” in Complexa's work from large pharmaceutical companies, Jafco officials said in a statement.

Add Alex Nixon to your Google+ circles.

Subscribe today! Click here for our subscription offers.

 

 

 


Show commenting policy

Most-Read Business Headlines

  1. PPG’s new CEO to push organic growth with existing clients
  2. Coal stocks on a roller coaster ride they can’t get off
  3. Judge rules against PPG in lawsuit over pollution
  4. Idea Foundry CEO Matesic decides which new companies get help from his Pittsburgh business incubator
  5. Coal company, UMW settle suit over use of non-union workers
  6. Comcast sets digital sights on millenials
  7. Dish and Sinclair agree in principle on new contract
  8. 2015 Chevrolet SS departs from the expected
  9. Steelworkers union says ATI talks to resume
  10. Protecting your identity from hackers
  11. Pittsburgh unemployment rate steady as job market shrinks